A systematic review of substance use screening in outpatient behavioral health settings
- PMID: 36967381
- PMCID: PMC10041696
- DOI: 10.1186/s13722-023-00376-z
A systematic review of substance use screening in outpatient behavioral health settings
Abstract
Objective: Despite the frequent comorbidity of substance use disorders (SUDs) and psychiatric disorders, it remains unclear if screening for substance use in behavioral health clinics is a common practice. The aim of this review is to examine what is known about systematic screening for substance use in outpatient behavioral health clinics.
Methods: We conducted a PRISMA-based systematic literature search assessing substance use screening in outpatient adult and pediatric behavioral health settings in PubMed, Embase, and PsycINFO. Quantitative studies published in English before May 22, 2020 that reported the percentage of patients who completed screening were included.
Results: Only eight articles met our inclusion and exclusion criteria. Reported prevalence of screening ranged from 48 to 100%, with half of the studies successfully screening more than 75% of their patient population. There were limited data on patient demographics for individuals who were and were not screened (e.g., gender, race) and screening practices (e.g., electronic versus paper/pencil administration).
Conclusions: The results of this systematic review suggest that successful screening for substance use in behavioral health settings is possible, yet it remains unclear how frequently screening occurs. Given the high rates of comorbid SUD and psychopathology, future research is necessary regarding patient and clinic-level variables that may impact the successful implementation of substance use screening. Trial registry A methodological protocol was registered with the PROSPERO systematic review protocol registry (ID: CRD42020188645).
Keywords: Behavioral health; Outpatient; Screening; Substance use; Substance use disorder.
© 2023. The Author(s).
Conflict of interest statement
AY is a consultant to the Gavin House and BayCove Human Services (clinical services), as well as the American Psychiatric Association's Providers Clinical Support System Sub-Award. TW has been a consultant for Neurovance/Otsuka, Ironshore, KemPharm, and Vallon, and he has a licensing agreement with Ironshore for a copyrighted diagnostic questionnaire that he co-owns (Before School Functioning Questionnaire). TW also serves as a clinical consultant to the US National Football League (ERM Associates), US Minor/Major League Baseline, Phoenix House/Gavin Foundation, and Bay Cove Human Services. There are no disclosures to report for the remaining authors.
References
-
- Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. 2020;156. https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFF.... Accessed 14 July 2022.
-
- National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking—50 years of progress: a report of the surgeon general. centers for disease control and prevention (US). 2014. https://www.ncbi.nlm.nih.gov/books/NBK179276/. Accessed 2 Aug. 2022. - PubMed
-
- Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts national center for health statistics. 2022. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 2 June 2022.
-
- Multiple Cause of Death 1999–2019 on CDC WONDER Online Database. Centers for disease control and prevention, national center for health statistics. 2020 https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Accessed 18 May 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous